WorksheetsJournal Club - NETT Trial
Total questions: 10
Worksheet time: 4mins
National Emphysema Treatment Trial (NETT) randomized how many patients
1218
1281
1291
1219
Improvement in QOL at 24 months for LVRS Group was 9%
True
False
Improvement in exercise capacity at 24 months
19%
14%
17%
15%
Emphysema distribution (Upper Lobe Predominant) was
63%
37
54
46
A post-hoc subgroup analysis demonstrated a mortality benefit for non-high-surgical risk patients with upper lobe disease and high baseline exercise tolerance.
True
False
Non-high-surgical risk patients with non-upper lobe disease and high exercise tolerance experienced an increased mortality rate.
True
False
Inclusion Criteria 1
TLC: ≥150%
RV: ≥100%
TLC: ≥100%
RV: ≥150%
TLC: ≥100%
RV: ≥100%
TLC: ≥150%
RV: ≥150%
Inclusion criteria 2
FEV1: ≤45%
Non-smoker for ≥ 4 months
FEV1: ≤35%
Non-smoker for ≥ 12 months
FEV1: ≤25%
Non-smoker for ≥6 months
FEV1: ≤20%
Non-smoker for ≥3 months
Exclusion Criteria
FEV1: ≤20%
CO diffusion ≤20%
6MWT <140 meters
FEV1: ≤40%
CO diffusion ≤40%
6MWT <160 meters
FEV1: ≤30%
CO diffusion ≤20%
6MWT <120 meters
FEV1: ≤15%
CO diffusion ≤25%
6MWT <140 meters
What was Mean FU of trial patients
27.4 Months
29.2 Months
29.4 Months
29.7 Months
